STATE STREET CORP - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$43,472
-61.2%
62,236
-50.0%
0.00%
Q4 2022$112,024
-70.0%
124,472
+100.0%
0.00%
Q3 2022$373,000
+109.6%
62,236
+44.6%
0.00%
Q2 2022$178,000
+8.5%
43,0360.0%0.00%
Q1 2022$164,000
+1.9%
43,036
+20.0%
0.00%
Q4 2021$161,000
+87.2%
35,860
+94.8%
0.00%
Q3 2021$86,000
-33.8%
18,4100.0%0.00%
Q2 2021$130,000
-88.5%
18,410
-90.4%
0.00%
Q1 2021$1,134,000
+38.8%
191,887
+8.2%
0.00%
Q4 2020$817,000
+30.3%
177,308
+10.1%
0.00%
Q3 2020$627,000
-84.1%
161,108
+17.4%
0.00%
Q2 2020$3,947,000
+166.0%
137,230
+99.0%
0.00%
Q1 2020$1,484,000
+84.3%
68,961
+68.6%
0.00%
Q4 2019$805,00040,8930.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders